Clinical Trial Update: Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial update on bevacizumab (Avastin) in combination with irinotecan for recurrent malignant glioma. The current trial status is listed as unknown in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Avastin (bevacizumab)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Recurrent Malignant Glioma | Phase 2 | Status: UNKNOWN